Laboratory Table of Contents

Search:

Laboratory Section

Policy Name	Date Modified
Allergy Tests of Uncertain Efficacy	08/01/2009
Analysis of Proteomic Patterns in Serum to Identify Cancer	04/01/2009
Assays of Genetic Expression in Tumor Tissue as a Technique to Determine Prognosis In Patients With Breast Cancer	05/01/2009
Biochemical Markers of Alzheimer's Disease	04/01/2009
Cervicography	11/01/2008
Collagen Cross Links as Markers of Bone Turnover	03/01/2009
Combination of Serum Markers for Liver Fibrosis in the Evaluation and Monitoring of Patients with Chronic Liver Disease	03/01/2009
Detection of Circulating Tumor Cells in the Management of Patients with Cancer	01/01/2009
Genetic Testing	11/01/2009
In-Vitro Chemoresistance and Chemosensitivity Assays	09/01/2008
Laboratory Tests for Heart Transplant Rejection	12/01/2008
Measurement of Long-Chain Omega-3 Fatty Acids in Red Blood Cell Membranes as a Cardiac Risk Factor	07/01/2008
Salivary Hormone Testing for Menopause and Aging	06/01/2009
Serum Holo-Transcobalamin as a Marker of Vitamin B12 (i.e., Cobalamin) Status	08/01/2009


	The Blue Cross and/or Blue Shield Plans comprising The Regence Group serve Idaho, Oregon, Utah and much of Washington state. The Regence Group and each of its affiliate Plans are independent licensees of the Blue Cross and Blue Shield Association.